Baseline cardiovascular risk in the INSIGHT Strategic Timing of AntiRetroviral Treatment trial

INTRODUCTION: The Strategic Timing of AntiRetroviral Treatment (START) trial has recruited antiretroviral-naïve individuals with high CD4 cell counts from all world regions. We describe the distribution of cardiovascular (CVD) risk factors, overall and by geographic region, at study baseline. METHOD...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:HIV Med
Main Authors: Soliman, Elsayed Z., Sharma, Shweta, Arastéh, Keikawus, Wohl, David, Achhra, Amit, Tambussi, Giuseppe, O’Connor, Jemma, Stein, James H., Duprez, Daniel A., Neaton, James D., Phillips, Andrew
Format: Artigo
Sprog:Inglês
Udgivet: 2015
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4341949/
https://ncbi.nlm.nih.gov/pubmed/25711323
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/hiv.12233
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker